• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床对恶性疟原虫的保护作用与被人血清抗体调理的疟原虫裂殖子诱导的中性粒细胞呼吸爆发有关。

Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies.

机构信息

Institut Pasteur de Dakar, Unité d'Immunologie, Dakar, Sénégal.

出版信息

PLoS One. 2010 Mar 25;5(3):e9871. doi: 10.1371/journal.pone.0009871.

DOI:10.1371/journal.pone.0009871
PMID:20360847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2845614/
Abstract

BACKGROUND

Effective vaccines to combat malaria are urgently needed, but have proved elusive in the absence of validated correlates of natural immunity. Repeated blood stage infections induce antibodies considered to be the main arbiters of protection from pathology, but their essential functions have remained speculative.

METHODOLOGY/PRINCIPAL FINDINGS: This study evaluated antibody dependent respiratory burst (ADRB) activity in polymorphonuclear neutrophils (PMN) induced by Plasmodium falciparum merozoites and antibodies in the sera of two different African endemic populations, and investigated its association with naturally acquired clinical protection. Respiratory bursts by freshly isolated PMN were quantified by chemiluminescence readout in the presence of isoluminol, which preferentially detects extra-cellular reactive oxygen species (ROS). Using a standardized, high throughput protocol, 230 sera were analyzed from individuals of all age groups living in meso- (Ndiop) or holo-endemic (Dielmo) Senegalese villages, and enrolled in a cross-sectional prospective study with intensive follow-up. Statistical significance was determined using non-parametric tests and Poisson regression models. The most important finding was that PMN ADRB activity was correlated with acquired clinical protection from malaria in both high and low transmission areas (P = 0.006 and 0.036 respectively). Strikingly, individuals in Dielmo with dichotomized high ADRB indexes were seventeen fold less susceptible to malaria attacks (P = 0.006). Complementary results showed that ADRB activity was (i) dependent on intact merozoites and IgG opsonins, but not parasitized erythrocytes, or complement, (ii) correlated with merozoite specific cytophilic IgG1 and IgG3 antibody titers (P<0.001 for both), and (iii) stronger in antisera from a holo-endemic compared to a meso-endemic site (P = 0.002), and reduced in asymptomatic carriers (P<0.001).

CONCLUSIONS/SIGNIFICANCE: This work presents the first clearly demonstrated functional antibody immune correlate of clinical protection from Plasmodium falciparum malaria, and begs the question regarding the importance of ADRB by PMN for immune protection against malaria in vivo.

摘要

背景

急需有效的疟疾疫苗,但由于缺乏天然免疫的有效指标,一直未能研制成功。反复的血期感染会诱导被认为是抵御病理损伤的主要保护作用的抗体,但这些抗体的基本功能仍然是推测性的。

方法/主要发现:本研究评估了裂殖体诱导的多形核粒细胞(PMN)依赖抗体的呼吸爆发(ADRB)活性,该活性在两种不同的非洲地方性人群的血清中被检测到,并研究了其与自然获得的临床保护的相关性。通过使用异鲁米诺进行化学发光读出,定量检测新鲜分离的 PMN 的呼吸爆发,异鲁米诺优先检测细胞外活性氧物种(ROS)。使用标准化的高通量方案,对来自居住在中(Ndiop)或全(Dielmo)塞内加尔村庄的各年龄段个体的 230 份血清进行分析,并纳入一项具有强化随访的前瞻性横断面研究。使用非参数检验和泊松回归模型确定统计学意义。最重要的发现是,PMN ADRB 活性与高、低传播地区疟疾的获得性临床保护相关(P=0.006 和 0.036)。引人注目的是,Dielmo 地区 ADRB 指数较高的个体患疟疾攻击的风险降低了 17 倍(P=0.006)。补充结果表明,ADRB 活性(i)依赖于完整的裂殖体和 IgG 调理素,但不依赖于感染的红细胞或补体,(ii)与裂殖体特异性细胞亲嗜性 IgG1 和 IgG3 抗体滴度相关(两者均 P<0.001),(iii)在全地方性地区比中地方性地区的抗血清中更强(P=0.002),并在无症状携带者中降低(P<0.001)。

结论/意义:本研究首次明确证明了临床保护免受恶性疟原虫疟疾的功能抗体免疫相关因素,并提出了PMN 依赖抗体的 ADRB 对体内抗疟免疫保护的重要性问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/a8ffd4373c2a/pone.0009871.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/69199040c6fc/pone.0009871.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/8f85af898abe/pone.0009871.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/ddcb45181626/pone.0009871.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/0c123c4e8a3a/pone.0009871.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/1524c88e4c2a/pone.0009871.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/ed780c82d3f7/pone.0009871.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/a8ffd4373c2a/pone.0009871.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/69199040c6fc/pone.0009871.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/8f85af898abe/pone.0009871.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/ddcb45181626/pone.0009871.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/0c123c4e8a3a/pone.0009871.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/1524c88e4c2a/pone.0009871.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/ed780c82d3f7/pone.0009871.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/730c/2845614/a8ffd4373c2a/pone.0009871.g007.jpg

相似文献

1
Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies.临床对恶性疟原虫的保护作用与被人血清抗体调理的疟原虫裂殖子诱导的中性粒细胞呼吸爆发有关。
PLoS One. 2010 Mar 25;5(3):e9871. doi: 10.1371/journal.pone.0009871.
2
Antibodies to Plasmodium falciparum merozoite surface protein-1p19 malaria vaccine candidate induce antibody-dependent respiratory burst in human neutrophils.针对恶性疟原虫裂殖子表面蛋白-1 p19疟疾疫苗候选物的抗体可诱导人中性粒细胞产生抗体依赖性呼吸爆发。
Malar J. 2015 Oct 15;14:409. doi: 10.1186/s12936-015-0935-5.
3
Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.恶性疟原虫的裂殖子表面蛋白1是获得性疟疾免疫个体中调理抗体的主要靶点。
Clin Vaccine Immunol. 2017 Nov 6;24(11). doi: 10.1128/CVI.00155-17. Print 2017 Nov.
4
Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.疟疾原虫裂殖子表面蛋白 4 型抗体与临床疟疾防护的相关性。
Vaccine. 2017 Dec 4;35(48 Pt B):6720-6726. doi: 10.1016/j.vaccine.2017.10.012. Epub 2017 Oct 15.
5
Improvement of the antibody-dependent respiratory burst assay for assessing protective immune responses to malaria.提高抗体依赖的呼吸爆发测定法来评估疟疾的保护性免疫反应。
Open Biol. 2022 Mar;12(3):210288. doi: 10.1098/rsob.210288. Epub 2022 Mar 16.
6
Association of antibody responses to the conserved Plasmodium falciparum merozoite surface protein 5 with protection against clinical malaria.针对恶性疟原虫裂殖子表面蛋白5保守区域的抗体反应与预防临床疟疾之间的关联。
PLoS One. 2014 Jul 21;9(7):e101737. doi: 10.1371/journal.pone.0101737. eCollection 2014.
7
Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against parasites.双同型免疫球蛋白增强抗体介导的中性粒细胞对寄生虫的活性。
Front Immunol. 2024 Apr 8;15:1360220. doi: 10.3389/fimmu.2024.1360220. eCollection 2024.
8
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.恶性疟原虫裂殖子的调理吞噬作用:人类免疫机制及疟疾保护性关联
BMC Med. 2014 Jul 1;12:108. doi: 10.1186/1741-7015-12-108.
9
Cytophilic Antibodies Against Key Plasmodium falciparum Blood Stage Antigens Contribute to Protection Against Clinical Malaria in a High Transmission Region of Eastern India.嗜细胞抗体针对恶性疟原虫血期关键抗原有助于在印度东部高传播地区预防临床疟疾。
J Infect Dis. 2018 Aug 14;218(6):956-965. doi: 10.1093/infdis/jiy258.
10
Assessment of the neutrophilic antibody-dependent respiratory burst (ADRB) response to Plasmodium falciparum.对恶性疟原虫的嗜中性粒细胞抗体依赖性呼吸爆发(ADRB)反应的评估。
J Leukoc Biol. 2014 Dec;96(6):1131-42. doi: 10.1189/jlb.4A0614-283RR. Epub 2014 Aug 12.

引用本文的文献

1
Markers of neutrophil activation and some immune and haematological indices in malaria infection during pregnancy.孕期疟疾感染中中性粒细胞活化标志物及一些免疫和血液学指标
BMC Immunol. 2025 Apr 8;26(1):28. doi: 10.1186/s12865-025-00709-4.
2
Ly6G Neutrophils and Interleukin-17 Are Essential in Protection against Rodent Malaria Caused by ANKA.Ly6G 中性粒细胞和白细胞介素-17 对于抵御由 ANKA 引起的啮齿类疟疾至关重要。
Research (Wash D C). 2024 Dec 19;7:0559. doi: 10.34133/research.0559. eCollection 2024.
3
How to Accelerate Early Stage of Malaria Vaccine Development by Optimizing Functional Assays.

本文引用的文献

1
Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum.针对恶性疟原虫裂殖子阶段的六种基于抗原的疟疾疫苗候选物的对比测试。
Clin Vaccine Immunol. 2008 Sep;15(9):1345-55. doi: 10.1128/CVI.00172-08. Epub 2008 Jun 11.
2
Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens.针对测量抗疟疾血液期抗原抗体功能活性的不同方法的批判性评估。
Am J Trop Med Hyg. 2006 Sep;75(3):437-42.
3
Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate.
如何通过优化功能测定来加速疟疾疫苗开发的早期阶段。
Vaccines (Basel). 2024 May 28;12(6):586. doi: 10.3390/vaccines12060586.
4
The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria.疟原虫驱动的免疫调节网络对疟疾免疫的影响。
Nat Rev Immunol. 2024 Sep;24(9):637-653. doi: 10.1038/s41577-024-01041-5. Epub 2024 Jun 11.
5
Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.全长 MSP1 是人体疟疾感染后保护性免疫的主要靶标。
Life Sci Alliance. 2024 May 20;7(8). doi: 10.26508/lsa.202301910. Print 2024 Aug.
6
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.Fc 介导的效应功能的广度与人类疟疾感染后的临床免疫相关。
Immunity. 2024 Jun 11;57(6):1215-1224.e6. doi: 10.1016/j.immuni.2024.05.001. Epub 2024 May 23.
7
Neutrophils versus Protozoan Parasites: , , , , and .中性粒细胞与原生动物寄生虫:……(此处原文未完整列出具体内容)
Microorganisms. 2024 Apr 19;12(4):827. doi: 10.3390/microorganisms12040827.
8
Uncovering the diversity of pathogenic invaders: insights into protozoa, fungi, and worm infections.揭示致病病原体的多样性:对原生动物、真菌和蠕虫感染的见解。
Front Microbiol. 2024 Mar 25;15:1374438. doi: 10.3389/fmicb.2024.1374438. eCollection 2024.
9
IgG Subclass Switch in Volunteers Repeatedly Immunized with the Full-Length Merozoite Surface Protein 1 (MSP1).用全长裂殖子表面蛋白1(MSP1)反复免疫的志愿者中的IgG亚类转换
Vaccines (Basel). 2024 Feb 17;12(2):208. doi: 10.3390/vaccines12020208.
10
Antibody-Dependent Respiratory Burst against Merozoites in Individuals Living in an Area with Declining Malaria Transmission.生活在疟疾传播率下降地区的个体针对裂殖子的抗体依赖性呼吸爆发
Vaccines (Basel). 2024 Feb 16;12(2):203. doi: 10.3390/vaccines12020203.
可溶性和糖脂修饰的杆状病毒恶性疟原虫C端裂殖子表面蛋白1,两种主要疟疾疫苗候选形式。
Vaccine. 2006 Aug 14;24(33-34):5997-6008. doi: 10.1016/j.vaccine.2006.04.069. Epub 2006 Jun 5.
4
Potency assay design for adjuvanted recombinant proteins as malaria vaccines.作为疟疾疫苗的佐剂重组蛋白的效价测定设计
Vaccine. 2006 May 15;24(20):4264-70. doi: 10.1016/j.vaccine.2006.01.005.
5
Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies.测量恶性疟原虫特异性生长抑制抗体的高通量方法的开发与优化。
J Clin Microbiol. 2006 May;44(5):1665-73. doi: 10.1128/JCM.44.5.1665-1673.2006.
6
Malaria: burden of disease.疟疾:疾病负担
Curr Mol Med. 2006 Mar;6(2):137-40. doi: 10.2174/156652406776055131.
7
Immune effector mechanisms in malaria.疟疾中的免疫效应机制。
Parasite Immunol. 2006 Jan-Feb;28(1-2):51-60. doi: 10.1111/j.1365-3024.2006.00808.x.
8
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.高水平的恶性疟原虫裂殖子表面蛋白2血清抗体与肯尼亚沿海地区临床疟疾风险降低相关。
Vaccine. 2006 May 8;24(19):4233-46. doi: 10.1016/j.vaccine.2005.06.030. Epub 2005 Jul 27.
9
[Re-assessment of culture inhibition assays and reinvasion of P. falciparum for the appraisal of immunity of individuals living in an endemic area].[对疟原虫培养抑制试验及恶性疟原虫再侵入的重新评估,用于评估流行地区居民的免疫力]
Dakar Med. 2002;47(1):5-11.
10
Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village.针对恶性疟原虫裂殖子表面蛋白1保守C端结构域、裂殖子提取物的抗体及其与体外抑制性抗体的关系以及在塞内加尔一个村庄预防临床疟疾的研究
J Infect Dis. 2005 Jan 15;191(2):264-71. doi: 10.1086/426398. Epub 2004 Dec 9.